97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details
臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03494764 (ClinicalTrials.gov) | September 7, 2017 | 4/4/2018 | Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares | Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-Center Randomized Trial | Colitis, Ulcerative | Other: Hyperbaric Oxygen Therapy | Dartmouth-Hitchcock Medical Center | Foundation for Clinical Research in IBD;The Eli and Edythe Broad Foundation;University of California, San Diego;Mayo Clinic;University of Pittsburgh Medical Center;Virginia Mason Memorial Hospital;University of Texas Southwestern Medical Center;University of Maryland, College Park;NYU Langone Health | Completed | 18 Years | N/A | All | 39 | Phase 2 | United States |
| 2 | NCT02144350 (ClinicalTrials.gov) | August 2013 | 13/5/2014 | Hyperbaric Oxygen for Ulcerative Colitis | Hyperbaric Oxygen Therapy for Moderate to Severe Ulcerative Colitis Flares: A Multi-center Randomized Double Blind Sham Controlled Trial | Ulcerative Colitis | Procedure: Hyperbaric oxygen;Procedure: Sham Hyperbaric Air | Dartmouth-Hitchcock Medical Center | Mayo Clinic;University of Pittsburgh | Terminated | 18 Years | N/A | All | 18 | Phase 2/Phase 3 | United States |